002332.SZ
Zhejiang Xianju Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 8.44
+0.00%Aug 27, 2026, 12:19 UTC
Xianju Pharmaceutical proposed a cash dividend of 1 yuan per 10 shares (tax included) to all shareholders.
Source:Aug 27, 2026, 12:19 UTC
Xianju Pharmaceutical disclosed its semi-annual report on August 27, reporting net profit attributable to shareholders of 245 million yuan, down 20.67% year-on-year.
Source:Aug 10, 2026, 08:55 UTC
Xianju Pharmaceutical's subsidiary Newchem signed a settlement agreement with Gedeon Richter and Estetra over a supply agreement dispute and received 10 million euros.
Source:Jul 22, 2026, 11:12 UTC
Xianju Pharmaceutical announced that as of July 22, 2026, it has repurchased 9.8929 million shares, representing 1.0001% of total shares, for a total cost of 81.9068 million yuan.
Source:Jul 10, 2026, 09:18 UTC
Xianju Pharmaceutical announced that 5 of its products, including progesterone capsules, were newly included in the 2026 edition of the National Essential Drugs List, effective September 1, 2026.
Source: